Does RUXOLITINIB Cause Lung infiltration? 61 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 61 reports of Lung infiltration have been filed in association with RUXOLITINIB (OPZELURA). This represents 0.1% of all adverse event reports for RUXOLITINIB.
61
Reports of Lung infiltration with RUXOLITINIB
0.1%
of all RUXOLITINIB reports
24
Deaths
42
Hospitalizations
How Dangerous Is Lung infiltration From RUXOLITINIB?
Of the 61 reports, 24 (39.3%) resulted in death, 42 (68.9%) required hospitalization, and 9 (14.8%) were considered life-threatening.
Is Lung infiltration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RUXOLITINIB. However, 61 reports have been filed with the FAERS database.
What Other Side Effects Does RUXOLITINIB Cause?
Off label use (12,492)
Death (6,561)
Fatigue (5,663)
Anaemia (3,593)
Haemoglobin decreased (3,297)
Platelet count decreased (3,028)
Diarrhoea (2,531)
Asthenia (2,529)
Dizziness (2,398)
Pneumonia (2,343)
What Other Drugs Cause Lung infiltration?
PREDNISONE (243)
RITUXIMAB (240)
CYCLOPHOSPHAMIDE (228)
METHOTREXATE (216)
ADALIMUMAB (172)
DOXORUBICIN (164)
VINCRISTINE (160)
PREDNISOLONE (151)
EVEROLIMUS (136)
CYTARABINE (124)
Which RUXOLITINIB Alternatives Have Lower Lung infiltration Risk?
RUXOLITINIB vs SABRIL
RUXOLITINIB vs SACCHAROMYCES CEREVISIAE
RUXOLITINIB vs SACITUZUMAB GOVITECAN
RUXOLITINIB vs SACITUZUMAB GOVITECAN-HZIY
RUXOLITINIB vs SACROSIDASE